![Thomas Saugnac](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Saugnac
Geschäftsführer bei Drugs for Neglected Diseases initiative
Aktive Positionen von Thomas Saugnac
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Drugs for Neglected Diseases initiative
![]() Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Geschäftsführer | - | - |
Karriereverlauf von Thomas Saugnac
Ausbildung von Thomas Saugnac
ESCP Europe Campus Paris | Graduate Degree |
Statistik
International
Schweiz | 2 |
Frankreich | 2 |
Operativ
Chief Operating Officer | 1 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Drugs for Neglected Diseases initiative
![]() Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Health Technology |
- Börse
- Insiders
- Thomas Saugnac
- Erfahrung